Study · Animal study (in vivo) · mouse · 1990
6 resultsZhao XH, Awaya A, Kobayashi H, Ohnuki T, Tokumitsu Y, Nomura Y
Japanese journal of pharmacology1 Jul 1990Cited by 12 (Europe PMC)
The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)
Text rights: CC BY-NC-ND. Results still quote short attributed sentences.
6 results from studies that gave the peptide. No result from this study comes from people.
In SAM-P/8 mice, FTS enhanced kidney Mn-SOD activity.
In plain wordsIn SAM-P/8 mice, FTS increased kidney Mn-SOD activity.
mousen: not reported in source
Senescence-accelerated mice aged 9-10 monthsSource sentences
FTS enhanced the activity of Mn-SOD and Cu,Zn-SOD in the kidney of SAM-P/8 and Cu,Zn-SOD activity in the brain of both SAM-P/8 and SAM-R/1.
In SAM-P/8 mice, FTS enhanced kidney Cu,Zn-SOD activity.
In plain wordsIn SAM-P/8 mice, FTS increased kidney Cu,Zn-SOD activity.
mousen: not reported in source
Senescence-accelerated mice aged 9-10 monthsSource sentences
FTS enhanced the activity of Mn-SOD and Cu,Zn-SOD in the kidney of SAM-P/8 and Cu,Zn-SOD activity in the brain of both SAM-P/8 and SAM-R/1.
In SAM-P/8 and SAM-R/1 mice, FTS enhanced brain Cu,Zn-SOD activity.
In plain wordsIn SAM-P/8 and SAM-R/1 mice, FTS increased brain Cu,Zn-SOD activity.
mousen: not reported in source
Senescence-accelerated mice aged 9-10 monthsSource sentences
FTS enhanced the activity of Mn-SOD and Cu,Zn-SOD in the kidney of SAM-P/8 and Cu,Zn-SOD activity in the brain of both SAM-P/8 and SAM-R/1.
In SAM-P/8 mice, FTS decreased liver MAO-B activity.
In plain wordsIn SAM-P/8 mice, FTS decreased liver MAO-B activity.
mousen: not reported in source
Senescence-accelerated mice aged 9-10 monthsSource sentences
It decreased the activity of MAO-B in the liver and the contents of malondialdehyde (MDA) in the brain and kidney of SAM-P/8.
In SAM-P/8 mice, FTS decreased brain malondialdehyde content.
In plain wordsIn SAM-P/8 mice, FTS decreased brain malondialdehyde content.
mousen: not reported in source
Senescence-accelerated mice aged 9-10 monthsSource sentences
It decreased the activity of MAO-B in the liver and the contents of malondialdehyde (MDA) in the brain and kidney of SAM-P/8.
In SAM-P/8 mice, FTS decreased kidney malondialdehyde content.
In plain wordsIn SAM-P/8 mice, FTS decreased kidney malondialdehyde content.
mousen: not reported in source
Senescence-accelerated mice aged 9-10 monthsSource sentences
It decreased the activity of MAO-B in the liver and the contents of malondialdehyde (MDA) in the brain and kidney of SAM-P/8.
AI wrote and checked these results. AI can make mistakes, so check important results against the source.
PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.
Version 2Current
21 Oct 2026, 15:58 UTC
Study results updated
Version 1
21 Oct 2026, 12:50 UTC
First added · source update from Europe PMC
Terms as the source lists them.
PepBank is a research reference. Talk to a doctor before you use any peptide.
In PepBank now:147 peptides, 6 blends and 13 other compounds97,577 study results from 17,383 studies8,473 clinical trialsUpdated